March 2, 2020 / 2:41 PM / in a month

BRIEF-ANI Pharma Announces FDA Approval Of Memantine Hydrochloride Extended-Release Capsules

March 2 (Reuters) - ANI Pharmaceuticals Inc:

* ANI PHARMACEUTICALS ANNOUNCES FDA APPROVAL OF MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES

* ANI PHARMA- GOT APPROVAL OF ANDA ROM U.S. FDA FOR MEMANTINE HYDROCHLORIDE EXTENDED-RELEASE CAPSULES 7 MG, 14 MG, 21 MG AND 28 MG Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below